连续性球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压的血流动力学变化
该研究纳入83例CTEPH患者,共行340例次BPA治疗,中位4.0次,扩张2104根血管。BPA后mPAP、PVR、WHO功能分级、6MWD、NT-proBNP均显著改善,前3疗程血流动力学改善最显著,并发症发生率9.4%,主要为肺出血。
要点
- BPA可显著改善CTEPH患者mPAP、PVR及功能状态
- 血流动力学获益主要出现在前3次BPA治疗
- 治疗血管支数越多,PVR和mPAP下降幅度越大
核心结论
- BPA可安全有效地治疗CTEPH患者
- BPA血流动力学改善具有累积效应,与总治疗血管数相关
研究设计与样本
- 单中心回顾性研究,纳入北京朝阳医院2017年10月至2022年1月确诊的CTEPH患者83例
- 83例患者中男27例、女56例,年龄53~68岁,中位年龄60岁,均至少接受1次BPA治疗
- 共行340例次BPA治疗,中位治疗次数4.0次,扩张病变血管2104根
主要发现
- mPAP从50.0(42.0~55.3)mmHg降至32.0(27.0~42.0)mmHg,P<0.001
- PVR从(806.6±323.2)dyn·s·cm-5降至420.0(295.0~613.5)dyn·s·cm-5,P<0.001
- 6MWD从364.5(300.0~429.5)m增加至461.0(409.0~501.0)m,P<0.001
- WHO功能分级Ⅰ/Ⅱ/Ⅲ/Ⅳ级患者数从0/35/34/14例变为43/32/7/1例,P<0.001
关键数值与推荐
- BPA前后mPAP、PVR、6MWD、NT-proBNP及WHO功能分级均较基线显著改善(均P<0.001)
- 血流动力学主要改善出现在前3次连续性BPA治疗
- 存在剂量-疗效关系:治疗血管支数越多,PVR和mPAP下降幅度越大
- BPA相关并发症发生率为9.4%,最常见为导管相关血管损伤引起肺出血
临床怎么用
- 对于技术不可手术的CTEPH患者,BPA可作为有效且安全的治疗选择
- BPA治疗应关注前3次疗程的血流动力学改善,并注意累计扩张血管数以获得更大获益
- 围术期需警惕导管相关血管损伤所致肺出血并发症
局限性
- 本研究为单中心回顾性研究,样本量83例
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To monitor hemodynamic changes during serial balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). Methods: General clinical data of CTEPH patients diagnosed from October 2017 to January 2022 in Beijing Chaoyang Hospital were collected, and 83 patients who underwent at least 1 BPA treatment were included to analyze their 6 min walking distance, WHO functional class, N-terminal B-type natriuretic peptide precursor (NT-proBNP), troponin I (cTnI) and haemodynamic indices. Baseline and follow-up after the final BPA clinical data and hemodynamics, functional status and serial hemodynamics before each series of BPA were collected to evaluate the efficacy of BPA for CTEPH patients. Complications and managements were documented to confirm the safety of BPA for CTEPH patients. Results: Three hundred and forty BPA procedures were performed in 83 CTEPH patients. The median number of BPA procedures was 4.0 and a total of 2104 vessels were dilated. In general, mPAP [from 50.0(42.0-55.25) mmHg(1 mmHg=0.133 kPa) to 32.0(27.0-42.0) mmHg, P<0.001], PVR[from (806.6±323.2) dyn·s·cm-5 to 420.0(295.0-613.5) dyn·s·cm-5, P<0.001] were significantly improved compared with baseline, but not CO and CI. Functional parameters including WHO functional class Ⅰ/Ⅱ/Ⅲ/Ⅳ (from 0/35/34/14 to 43/32/7/1, P<0.001), 6MWD [from 364.5(300.0-429.5)m to 461.0(409.0-501.0)m, P<0.001], NT-proBNP [from 1 357.0(232.0-2 715.0) ng/L to 141.0(57.0-627.8) ng/L,P<0.001] were significantly improved compared with baseline. A cumulative (compared to baseline) and serial (compared to preceding BPA session) analysis of the sequential BPA session confirmed that a major hemodynamic improvement in PVR and mPAP occurred in the first 3 serial BPA treatments. There was a dose-response relationship: the more segments that were treated, the greater were the subsequent reduction in PVR and mPAP. There were 32.0 complications (9.4%) associated with BPA procedures, and the most common complication was pulmonary hemorrhage caused by catheter-related vascular injury. Conclusions: BPA is an effective and safe alternative for technically non-operable CTEPH patients. The hemodynamic benefits of BPA in CTEPH patients were cumulative and correlated with the total number of vessels successfully dilated. 目的: 观察连续性球囊肺动脉扩张成形术(BPA)治疗慢性血栓栓塞性肺动脉高压(CTEPH)患者血流动力学变化。 方法: 收集北京朝阳医院2017年10月至2022年1月确诊的CTEPH患者一般临床资料,纳入83例至少进行1次BPA治疗的患者,其中男27例,女56例,年龄53~68岁,中位年龄60岁。分析患者基线及每个疗程BPA前、最后1次BPA治疗后至少随访1个月时的6 min步行距离、WHO功能分级、N末端B型利钠肽前体(NT-proBNP)、肌钙蛋白I(cTnI)及血流动力学指标。收集手术次数、扩张血管根数,每次BPA围术期的并发症情况,记录并发症的处理措施。 结果: 本研究83例患者共进行BPA治疗340例次,治疗中位次数为4.0次,扩张了2 104根病变血管。BPA治疗前后,患者mPAP从50.0(42.0~55.3)mmHg(1 mmHg=0.133 kPa)降至32.0(27.0~42.0)mmHg,PVR从(806.6±323.2)dyn·s·cm-5降至420.0(295.0~613.5)dyn·s·cm-5;WHO功能分级Ⅰ、Ⅱ、Ⅲ、Ⅳ级患者数量从0、35、34、14例改变为43、32、7、1例,6 min步行距离从364.5(300.0~429.5)m增加至461.0(409.0~501.0)m、NT-proBNP从1 357.0(232.0~2 715.0)ng/L降至141.0(57.0~627.8)ng/L(均P<0.001)。PVR和mPAP等血流动力学指标在前3疗程治疗后改善最显著,存在剂量-疗效关系:治疗血管支数越多,PVR和mPAP下降幅度越大。出现32例次与BPA治疗相关的并发症,发生率为9.4%(32/340),主要并发症为导管相关血管损伤引起肺出血。 结论: BPA可安全有效地治疗CTEPH患者,血流动力学改善具有累积效应,与总治疗的血管数相关。.
引用
- Wang W, Gong JN, Wang JF, et al. [Hemodynamic changes with serial balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension]. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309960. doi:10.3760/cma.j.cn112147-20231016-00237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。